Hair follicle-derived IL-7 and IL-15 are crucial for maintaining skin-resident memory Tcells and could be targeted for treating skin diseases and lymphoma.
July 2025 in “Journal of Investigative Dermatology”
Three molecular subtypes of advanced skinT-celllymphoma were identified, with potential biomarkers for predicting treatment response and disease progression.
A user diagnosed with lymphoma is advised to stop finasteride during chemotherapy, with suggestions to consider treatments like Dutasteride and Minoxidil post-recovery. The focus is on prioritizing health over hair loss, with encouragement and advice from others who have experienced similar situations.
CRISPR shows promise for treating hair loss by targeting specific genes. Currenttreatments include Minoxidil and finasteride, but CRISPR could offer a more precise solution, though it is still expensive and in early stages.
Rosemary extract showed high inhibitory activity against DHT, similar to finasteride and dutasteride, butthe conversation includes skepticism about its effectiveness in humans since the study was done on mice and rosemary oil is often considered ineffective based on personal experiences. Some suggesttrying rosemary oil alongside other treatments, while others emphasize the difference between the extract used in the study and the oil.
RT1640, a combination of cyclosporin A, minoxidil, and RT175, is discussed as a potential treatment for hair regrowth and repigmentation. The unique formulation aims to enhance hair follicle growth and restore hair pigment withoutthe negative side effects of immunosuppressants.
Way-316606 is considered a potential hair loss treatment but is avoided due to safety concerns and lack of research. Minoxidil and Finasteride are preferred as established treatments.